Listing Date Delayed for Paid-in Capital Increase
한국유니온제약
080720
Signal Score
Historical Avg Return (5d)
+0.25%
Data Coverage
100%n=2486
Risk-adjusted indicator based on 2486 historical DART filings. For informational purposes only — not investment advice.
Financial Impact
NEUTRAL
Key Numbers
- • New Listing Date: July 22, 2026
- • Original Listing Date: July 15, 2026
- • Initial Filing Date: May 18, 2026
- • Court Approval Date for Rehabilitation Plan: May 12, 2026
AI Analysis Summary
UNION KOREA PHARM CO.,Ltd announced an amendment to its Material Fact Report regarding a paid-in capital increase. The new listing date for the new shares has been postponed by one week, from July 15, 2026, to July 22, 2026, due to administrative procedures with the Korea Securities Depository. The company received court approval for its rehabilitation plan on May 12, 2026, which includes a debt-to-equity swap, capital reduction, and a third-party allocation capital increase. The capital increase is expected to result in a change of the largest shareholder. The delay is minor and procedural, suggesting a neutral short-term impact.
How This Event Is Evaluated
Capital Raise Evaluation
Capital raise events are evaluated by estimating dilution pressure, funding purpose, pricing terms, and impact on existing shareholders.
AI is used to interpret disclosures and extract structured data.
Signal scores are generated using event-specific methodologies and quantitative models.
- Potential dilution rate
- Issuance or conversion price
- Funding purpose
- Shareholder value impact
Track Korean Market Signals — Free
Sign up free to access live disclosures, AI analysis, and event filters.
Public Beta · No credit card required
This content is for informational purposes only and does not constitute investment advice. Past signal patterns do not guarantee future results. All data is sourced from public DART filings.